Holding(s) in Company

RNS Number : 5173J

Venn Life Sciences Holdings PLC

07 April 2015

 

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Notification of Shareholding

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, has been informed by David Newton that he holds 2,200,000 ordinary shares of 0.1 pence each, representing 5.61 per cent. of the Company's issued share capital.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer	Tel: [phone]
Zeus Capital Limited (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones	Tel: [phone]
Alex Davies	Tel: [phone]
Walbrook PR Ltd Paul McManus	Tel: [phone] or [e-mail] Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

HOLEADLXEDPSEFF